Braeburn Pharmaceuticals, Inc. — Form D

Braeburn Pharmaceuticals, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-19. The offering totals $110.0M, of which $110.0M was reported sold. Industry: Biotechnology.

Offering

Filed: 2018-01-19
Form: D
Accession: 0001140361-18-002621
Industry: Biotechnology
Exemptions: 06b
Total offering: $110.0M
Amount sold: $110.0M
Investors: 8
Date of first sale: 2018-01-08
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-303731

Issuer

Name: Braeburn Pharmaceuticals, Inc.
CIK: 0001688765
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 47 HULFISH STREET, PRINCETON, NJ, 08542
Phone: 609-751-5375

Officers, directors & promoters (11)

Name	Role	Location
Jeffrey L Berkowitz	Director	Coconut Grove, FL
Michael Derkacz	Director	Princeton, NJ
Seth L Harrison, M.D.	Director	Princeton, NJ
Argeris L Karabelas, Ph.D.	Director	Princeton, NJ
Patrick L Kennedy	Director	Princeton, NJ
Dennis H Langer, J. D., M.D.	Director	Princeton, NJ
Brian H Markison	Director	Princeton, NJ
Michael Derkacz	Executive Officer	Princeton, NJ
Seth L Harrison, M.D.	Executive Officer	Princeton, NJ
David J McIntyre	Executive Officer	Princeton, NJ
Asher M Rubin	Executive Officer	San Diego, CA

More